Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Minimization of immunosuppression].

E Thervet1

  • 1Hôpital Saint-Louis, Paris.

Presse Medicale (Paris, France : 1983)
|October 2, 2001
PubMed
Summary
This summary is machine-generated.

Minimization protocols aim to reduce immunosuppression after transplantation. Careful corticosteroid tapering and strategic use of mycophenolate mofetil (MMF) or sirolimus can help manage immunosuppression, especially in patients with renal impairment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Specificities of Meningitis and Meningo-Encephalitis After Kidney Transplantation: A French Retrospective Cohort Study.

Transplant international : official journal of the European Society for Organ Transplantation·2023
Same author

Acute kidney injury after valacyclovir administration for prevention of congenital cytomegalovirus infection.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.

Scandinavian journal of rheumatology·2021
Same author

Trajectory of extracellular fluid volume over time and subsequent risks of end-stage kidney disease and mortality in chronic kidney disease: a prospective cohort study.

Journal of internal medicine·2020
Same author

Diagnosis of congenital toxoplasmosis in a renal transplant recipient mother.

Journal of gynecology obstetrics and human reproduction·2017
Same author

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Area of Science:

  • Nephrology
  • Transplant Medicine
  • Clinical Pharmacology

Background:

  • Long-term immunosuppression post-transplantation carries risks and economic implications.
  • Minimization protocols seek to reduce the cumulative burden of immunosuppressive drugs.
  • Optimizing immunosuppression is crucial for patient outcomes and healthcare costs.

Purpose of the Study:

  • To evaluate the efficacy and safety of various immunosuppression minimization protocols.
  • To assess the impact of discontinuing specific immunosuppressant agents, including corticosteroids, mycophenolate mofetil (MMF), and calcineurin inhibitors.
  • To identify strategies for reducing immunosuppression in stabilized transplant recipients, particularly those with renal dysfunction.

Main Methods:

  • Review of existing data on different immunosuppression minimization strategies.

Related Experiment Videos

  • Analysis of outcomes associated with corticosteroid discontinuation, MMF withdrawal, and calcineurin inhibitor (cyclosporine) reduction or cessation.
  • Examination of the role of MMF and sirolimus in facilitating the reduction of other immunosuppressants.

    • Main Results:

    • Corticosteroid therapy should be carefully tapered late after transplantation, even with newer immunosuppressants.
    • Discontinuation of mycophenolate mofetil (MMF) carries risks, and its benefits require further demonstration.
    • Complete withdrawal of cyclosporine in stabilized patients may not outweigh the risks, but MMF can aid in its tapering.
    • In renal impairment, MMF or sirolimus can enable cyclosporine dose reduction or complete withdrawal.

    Conclusions:

    • Immunosuppression minimization requires careful patient selection and strategic drug management.
    • Late tapering of corticosteroids is advised. MMF's role in discontinuation needs more evidence.
    • Calcineurin inhibitor withdrawal should be approached cautiously; MMF and sirolimus offer valuable alternatives for dose reduction, especially in renal impairment.